Medical equipment

Avacta’s Diagnostic Division Achieves ISO 13485 Certification

Retrieved on: 
Wednesday, July 14, 2021

The ISO 13485 standard defines the comprehensive requirements for quality management for a developer and legal manufacturer of diagnostic products and medical devices.

Key Points: 
  • The ISO 13485 standard defines the comprehensive requirements for quality management for a developer and legal manufacturer of diagnostic products and medical devices.
  • ISO 13485 certification means that the CE mark for the AffiDX SARS-CoV-2 antigen lateral flow test can be transferred to Avacta from its partner, Mologic, and Avacta will be legal manufacturer of all future in-vitro diagnostic products.
  • Dr Alastair Smith, Chief Executive Officer of Avacta Group, commented: We are delighted that Avactas diagnostics division has achieved ISO 13485 certification.
  • ISO 13485 certification is recognised globally by our partners, customers and regulatory bodies alike as the medical device industry benchmark for quality.

Aviv Clinics officially opens in JLT, Dubai, U.A.E

Retrieved on: 
Wednesday, July 14, 2021

at Aviv Clinics .Those seeking the best of cutting-edge medicine will be able to receive it in Dubai and will not need to travel abroad.

Key Points: 
  • at Aviv Clinics .Those seeking the best of cutting-edge medicine will be able to receive it in Dubai and will not need to travel abroad.
  • Aviv has designed a program that is easy to understand including HBOT treatment, cognitive and physical training and nutrition.
  • Aviv Clinics focuses on brain performance and the clinic's specialty wings offer the latest advancements in assessing, treating, and improving cognitive and physical performance:
    1.
  • Aviv is excited and proud to open this first facility in Dubai and play its role in supporting the U.A.E.

Aviv Clinics officially opens in JLT, Dubai, U.A.E

Retrieved on: 
Wednesday, July 14, 2021

at Aviv Clinics .Those seeking the best of cutting-edge medicine will be able to receive it in Dubai and will not need to travel abroad.

Key Points: 
  • at Aviv Clinics .Those seeking the best of cutting-edge medicine will be able to receive it in Dubai and will not need to travel abroad.
  • Aviv has designed a program that is easy to understand including HBOT treatment, cognitive and physical training and nutrition.
  • Aviv Clinics focuses on brain performance and the clinic's specialty wings offer the latest advancements in assessing, treating, and improving cognitive and physical performance:
    1.
  • Aviv is excited and proud to open this first facility in Dubai and play its role in supporting the U.A.E.

Diamond Braces Has Answers to Questions About NYC Orthodontics

Retrieved on: 
Tuesday, July 13, 2021

For patients based in New York City who are interested in learning more about orthodontic care and Invisalign treatment, Diamond Braces has launched pages dedicated to answering popular questions that Manhattan orthodontic patients may have.

Key Points: 
  • For patients based in New York City who are interested in learning more about orthodontic care and Invisalign treatment, Diamond Braces has launched pages dedicated to answering popular questions that Manhattan orthodontic patients may have.
  • Among the questions answered are:
    Can I visit an orthodontist in NYC without a referral?
  • Patients interested in learning more about orthodontic care can visit Diamond Braces' new NYC orthodontist information page here and residents interested in Invisalign treatment can visit the dedicated Invisalign therapy NYC page here starting today.
  • Diamond Braces, a Diamond Plus Invisalign Provider, is a leader in high-quality orthodontic care on the East Coast.

AdaptHealth Corp. Schedules Second Quarter 2021 Financial Results and Conference Call

Retrieved on: 
Tuesday, July 13, 2021

AdaptHealth Corp. (NASDAQ: AHCO) (AdaptHealth or the Company), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that it will release its financial results for the second quarter ended June 30, 2021 before the opening of the financial markets on Thursday, August 5, 2021.

Key Points: 
  • AdaptHealth Corp. (NASDAQ: AHCO) (AdaptHealth or the Company), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that it will release its financial results for the second quarter ended June 30, 2021 before the opening of the financial markets on Thursday, August 5, 2021.
  • Management will host a conference call that morning at 8:30 am ET to discuss the results and business activities.
  • AdaptHealth is a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services.
  • AdaptHealth services nearly 3 million patients annually in all 50 states through its network of over 500 locations in 47 states.

Global consulting firm Star acquires Pro4People, creating powerhouse in MedTech development and regulatory consulting

Retrieved on: 
Tuesday, July 13, 2021

With this acquisition, Star has deepened its MedTech capabilities, expanding its already extensive offering.

Key Points: 
  • With this acquisition, Star has deepened its MedTech capabilities, expanding its already extensive offering.
  • "The complex regulatory approval process is a significant challenge for all companies looking to bring MedTech and Digital Healthcare solutions to market.
  • Star is a global technology company that connects strategy, design and engineering services and helps companies to accelerate their product innovation.
  • They assist clients in all phases of the software development lifecycle: research, development, maintenance and delivery to create modern, global, compliant and connected medical devices.

Global consulting firm Star acquires Pro4People, creating powerhouse in MedTech development and regulatory consulting

Retrieved on: 
Tuesday, July 13, 2021

With this acquisition, Star has deepened its MedTech capabilities, expanding its already extensive offering.

Key Points: 
  • With this acquisition, Star has deepened its MedTech capabilities, expanding its already extensive offering.
  • "The complex regulatory approval process is a significant challenge for all companies looking to bring MedTech and Digital Healthcare solutions to market.
  • Star is a global technology company that connects strategy, design and engineering services and helps companies to accelerate their product innovation.
  • They assist clients in all phases of the software development lifecycle: research, development, maintenance and delivery to create modern, global, compliant and connected medical devices.

Bearaby Launches Sustainable Travel Weighted Blanket

Retrieved on: 
Tuesday, July 13, 2021

BROOKLYN, N.Y., July 13, 2021 /PRNewswire/ -- Bearaby , the brand providing rejuvenating rest through sustainable weighted blankets, is pleased to announce the launch of the Travel Napper a 10lb travel weighted blanket designed to help you feel calmer and sleep better no matter where you are.

Key Points: 
  • BROOKLYN, N.Y., July 13, 2021 /PRNewswire/ -- Bearaby , the brand providing rejuvenating rest through sustainable weighted blankets, is pleased to announce the launch of the Travel Napper a 10lb travel weighted blanket designed to help you feel calmer and sleep better no matter where you are.
  • Using its patented weighted yarn, the Travel Napper features a tighter looped high-density material giving it weight and flexibility at the same time.
  • Like all Bearaby products, the Travel Napper and its packaging are plastic-free, 100% biodegradable, and MADE IN GREEN by OEKO-Tex certified.
  • Convenient for on-the-go use, the 40" x 64" Bearaby Travel Weighted Blanket retails at $209 and comes in a lightweight, weekender-style canvas bag for easy transportation.

Global Respiratory Care Devices Markets, 2015-2020 & 2021-2026: Chronic Obstructive Pulmonary Disease, Asthma, Sleep Apnea, Infectious Disease - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 13, 2021

The global respiratory care devices market exhibited strong growth during 2015-2020.

Key Points: 
  • The global respiratory care devices market exhibited strong growth during 2015-2020.
  • Looking forward, the global respiratory care devices market to grow at a CAGR of around 11% during the forecast period (2021-2026).
  • Nebulizers, inhalers, positive airway pressure (PAP) devices, spirometers, humidifiers, etc., are some of the most commonly used respiratory care devices.
  • What is the structure of the global respiratory care devices industry and who are the key players?

Xenios AG receives approval in China for ECMO devices

Retrieved on: 
Tuesday, July 13, 2021

In early May, Xenios AG, a Fresenius Medical Care company, received approval for two patient kits in China.

Key Points: 
  • In early May, Xenios AG, a Fresenius Medical Care company, received approval for two patient kits in China.
  • As a result, a complete Xenios system is now permitted for ECMO therapy in China.
  • This Xenios ECMO complete system is certified in China for nine days application period.
  • The expedited approval was a joint effort by Xenios and Fresenius Medical Care China Team.